Pharmacokinetic/Pharmacodynamic Background and Methods and Scientific Evidence Base for Dosing of Second-line Tuberculosis Drugs.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 30496455.
- Also identified by DOI 10.1093/cid/ciy608 and PMC identifier 6260166.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A World Health Organization workshop systematically examined the evidence base for dosing second-line tuberculosis drugs, identifying knowledge gaps. To fill these in, pharmacokinetics/pharmacodynamics, Monte Carlo experiments, and artificial intelligence algorithms were used in hollow-fiber model studies and clinical data analyses.
Medical subject headings
- Antitubercular Agents
- Mycobacterium tuberculosis
- Tuberculosis